000 | 04957nam a22006135i 4500 | ||
---|---|---|---|
001 | 978-981-13-1486-5 | ||
003 | DE-He213 | ||
005 | 20210201191326.0 | ||
007 | cr nn 008mamaa | ||
008 | 180927s2018 si | s |||| 0|eng d | ||
020 |
_a9789811314865 _9978-981-13-1486-5 |
||
050 | 4 | _aRC261-271 | |
072 | 7 |
_aMJCL _2bicssc |
|
072 | 7 |
_aMED062000 _2bisacsh |
|
072 | 7 |
_aMJCL _2thema |
|
082 | 0 | 4 |
_a614.5999 _223 |
245 | 1 | 0 |
_aRole of Tyrosine Kinases in Gastrointestinal Malignancies _h[electronic resource] / _cedited by Ganji Purnachandra Nagaraju. |
250 | _a1st ed. 2018. | ||
264 | 1 |
_aSingapore : _bSpringer Singapore : _bImprint: Springer, _c2018. |
|
300 |
_aXV, 241 p. 28 illus., 21 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
500 | _aAcceso multiusuario | ||
505 | 0 | _aChapter 1. 1. Overview of tyrosine kinases and their receptors in gastrointestinal malignancies- -- Chapter 2. EGFR and Erb-B2R (HER2): their role in Esophagus cancer -- Chapter 3. HGFR and FGFR2: their role in progression and metastasis of Esophagus cancer -- Chapter 4. Role of Src and VEGF R tyrosine kinases in Esophagus cancer -- Chapter 5. HGF receptor tyrosine kinase in gastric cancer. - Chapter 6. The EGF/ErbB receptor family of tyrosine kinases in gastric cancer -- Chapter 7. Helicobacter pylori CagA protein: its role and interaction tyrosine kinases in gastric cancer -- Chapter 8. RON receptor tyrosine kinase in pancreatic cancer progression -- Chapter 9. EGFR and Cytoplasmic kinases Src targeting in pancreatic cancer -- Chapter 10. VEGF and PDGFR targeting in pancreatic cancer -- Chapter 11. c-KIT, and FLT-3: their role in Hepatocellular carcinoma -- Chapter 12. VEGFR, and PDGFR: their targeting in Liver Cancer -- Chapter 13. EGFR and FGFR in growth and metastasis of colorectal cancer -- Chapter 14. VEGFR, and PDGFR: their targeting in colorectal cancerm -- Chapter 15. Nano materials and their impact on tyrosine kinase on selected gastrointestinal malignancies -- Chapter 16. Tyrosine kinase inhibitors and their clinical prospective in gastrointestinal malignancies -- Chapter 17. Drug resistance against tyrosine kinase inhibitors in gastrointestinal malignancies -- Chapter 18. Tyrosine kinases: their expression, diagnostic, therapeutic and prognostic aspects in gastrointestinal cancers. | |
520 | _aThe aim of this book is to provide comprehensive overview of the role of different tyrosine kinases in the progression and metastasis of various cancers of the gastrointestinal tract such as esophagus, liver, pancreas, stomach, and colorectal. Activation of various signaling pathways and tyrosine kinases are responsible for resistance to chemo and radiotherapy in these gastrointestinal malignancies. Targeting these tyrosine kinases, which regulate the activities of survival pathways in growth, and metastasis is a rational strategy in gastrointestinal cancer therapy. Each chapter embedded in this book covers information pertaining to a specific tyrosine kinase and its impact on various malignancies, which is not only significant for basic and clinical research investigations but will also be valued by students at advanced undergraduate to postgraduate levels. | ||
541 |
_fUABC ; _cTemporal ; _d01/01/2021-12/31/2023. |
||
650 | 0 | _aCancer research. | |
650 | 0 | _aHuman physiology. | |
650 | 0 | _aCell biology. | |
650 | 0 | _aProteins . | |
650 | 0 | _aGene expression. | |
650 | 0 | _aOncology . | |
650 | 1 | 4 |
_aCancer Research. _0https://scigraph.springernature.com/ontologies/product-market-codes/B11001 |
650 | 2 | 4 |
_aHuman Physiology. _0https://scigraph.springernature.com/ontologies/product-market-codes/B13004 |
650 | 2 | 4 |
_aCell Biology. _0https://scigraph.springernature.com/ontologies/product-market-codes/L16008 |
650 | 2 | 4 |
_aReceptors. _0https://scigraph.springernature.com/ontologies/product-market-codes/L14110 |
650 | 2 | 4 |
_aGene Expression. _0https://scigraph.springernature.com/ontologies/product-market-codes/B12010 |
650 | 2 | 4 |
_aOncology. _0https://scigraph.springernature.com/ontologies/product-market-codes/H33160 |
700 | 1 |
_aNagaraju, Ganji Purnachandra. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9789811314858 |
776 | 0 | 8 |
_iPrinted edition: _z9789811314872 |
776 | 0 | 8 |
_iPrinted edition: _z9789811346408 |
856 | 4 | 0 |
_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=https://doi.org/10.1007/978-981-13-1486-5 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c242168 _d242167 |